![](/img/cover-not-exists.png)
Long‐term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first‐line biologics
Inokuchi, Toshihiro, Takahashi, Sakuma, Hiraoka, Sakiko, Toyokawa, Tatsuya, Takagi, Shinjiro, Takemoto, Koji, Miyaike, Jiro, Fujimoto, Tsuyoshi, Higashi, Reiji, Morito, Yuki, Nawa, Toru, Suzuki, SeiyuJournal:
Journal of Gastroenterology and Hepatology
DOI:
10.1111/jgh.14624
Date:
February, 2019
File:
PDF, 678 KB
2019